Abbott Laboratories (Pakistan) Limited (PSX: ABOT)

Market Cap	97.31B
Revenue (ttm)	63.81B
Net Income (ttm)	5.00B
Shares Out	97.90M
EPS (ttm)	51.10
PE Ratio	19.45
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,624
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	399.99 - 1,060.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company offers portfolio of products in various therapeutic areas, including women’s and men’s health, gastroenterology, central nervous system, pediatrics, vitamins, cardiometabolic and metabolic, pain and f...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,430
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2023, ABOT's revenue was 55.48 billion, an increase of 12.62% compared to the previous year's 49.26 billion. Earnings were 261.78 million, a decrease of -91.29%.